Plasmodium falciparum: Selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 1, 1999, Pages 125-130

  Jelinek, T ^a   Kilian, A H D ^b   Curtis, J ^c   Duraisingh, M T ^c   Kabagambe, G ^d   Von Sonnenburg, F ^a   Warhurst, D C ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Ger Soc for Technical Cooperation   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ARGININE; ASPARAGINE; COTRIMOXAZOLE; CYSTEINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FOLIC ACID ANTAGONIST; GLUTAMIC ACID; GLYCINE; ISOLEUCINE; LYSINE; SERINE;

ALLELE; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; INFANT; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; UGANDA;

EID: 0032765836     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.125     Document Type: Article

References (30)

1. O'Dempsey T, McArdle T, Laurence B, Lamont A, Greenwood B, 1993. Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg 87: 662-665.
2. WHO: Division of Diarrhoeal and Acute Respiratory Disease Control, 1995. Integrated management of the sick child. Bull World Health Organ 73: 735-740.
3. Bloland PB, Redd SC, Kazembe P, Tembenu R, Wirima JJ, Campbell CC, 1991. Co-trimoxazole for childhood febrile illness in malaria-endemic regions. Lancet 337: 518-520.
4. Daramola OO, Alonso PL, O'Dempsey T, Twumasi P, McArdle T, Greenwood B, 1991. Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole. Trans R Soc Trop Med Hyg 85: 345-348.
5. Peterson D, Walliker D, Wellems T, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85: 9114-9118.
6. Triglia T. Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.
7. Brooks D, Wang P, Read M, Watkin W, Sims P, Hyde J, 1994. Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthetase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
8. Plowe C, Cortese J, Djimde A, Nwanyanwu O, Watkins W, Winstanley P, Estrada-Franco J, Mollinedo R, Avila J, Cespedes J, Carter D, Doumbo O, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176: 1590-1596.
9. Triglia T, Menting J, Wilson C, Cowman A, 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94: 13944-13949.
10. Wang P, Reed M, Sims P, Hyde J, 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 23: 979-986.
11. Wang P, Brooks DR, Sims PF, Hyde JE, 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71: 115-125.
12. Kilian A, Jelinek T, Prislin I, Kabagambe G, Byamukama W, Mpigika G, Korte R, von Sonnenburg F, 1998. Resistance in vivo of P. falciparum to co-trimoxazole in western Uganda. Trans R Soc Trop Med Hyg 92: 197-200.
13. Eldin de Pecoulas P, Basco L, Abdallah B, Dje M, Le Bras J, Mazabraud A, 1995. Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. Exp Parasitol 80: 483-487.
14. Cowman A, Morry M, Biggs B, Cross G, Foote S, 1988. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85: 9109-9113.
15. Zolg J, Plitt J, Chen G, Palmer S, 1989. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36: 253-262.
16. Peterson D, Milhous W, Wellems T, 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
17. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
18. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
19. Duraisingh M, Curtis J, Warhurst D, 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate dynthetase genes by PCR and restriction digestion. Exp Parasitol 89: 1-8.
20. Anonymous, 1994. Antimalarial Drug Policies: Data Requirements, Treatment of Uncomplicated Malaria and Management of Malaria in Pregnancy. Geneva: World Health Organization.
21. Anonymous, 1996. Assessment of the Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization. MAL/96.1077.
22. Wooden J, Kyes S, Sibley C, 1993. PCR and strain identification in Plasmodium falciparum. Parasitol Today 9: 303-305.
23. Jelinek T, Pröll S, Hess F, von Sonnenburg F, Kabagambe K, Löscher T, Kilian AHD, 1996. Geographical differences in the sensitivity of polymerase chain reaction for detection of P. falciparum infection in Uganda. Am J Trop Med Hyg 55: 647-651.
24. Pääbo S, 1990. Amplifying ancient DNA. Innis M, Gelfand D, Sninsky J, White T, eds. PCR Protocols. London: Academic Press, 159-166.
25. Wang P, Lee C, Bayoumi R, Djimde A, Doumbo O, Swedberg G, 1997. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 89: 161-177.
26. Curtis J, Duraisingh M, Trigg J, Mbwana H, Warhurst D, Curtis C, 1996. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Trans R Soc Trop Med Hyg 90: 678-680.
27. Foote S, Galatis D, Cowman A, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
28. Martin D, Arnold J, 1968. Treatment of acute falciparum malaria with sulfalene and trimethoprim. JAMA 203: 476-477.
29. Petersen E, 1987. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim, and sulphamethoxazole, singly and in combination. Trans R Soc Trop Med Hyg 81: 238-241.
30. Wu Y, Kirkman LA, Wellems TE, 1996. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci USA 93: 1130-1134.